sub:assertion {
  d:DB00169 dv:ddi-interactor-in dr:DB00169_DB01083 .
  d:DB01083 dv:ddi-interactor-in dr:DB00169_DB01083 .
  dr:DB00169_DB01083 dcterms:identifier "drugbank_resource:DB00169_DB01083" ;
    dcterms:title "DDI between Cholecalciferol and Orlistat - Orlistat may decrease the serum concentration of Vitamin D analogs. More specifically, orlistat may impair absorption of Vitamin D analogs such as cholecalciferol. Monitor clinical response (plasma calcium concentrations) to orally administered vitamin D analogs closely if used with orlistat. When this combination must be used, consider administering the vitamin D analog at least 2 hours before or after the administration of orlistat."@en ;
    a dv:Drug-Drug-Interaction ;
    rdfs:label "DDI between Cholecalciferol and Orlistat - Orlistat may decrease the serum concentration of Vitamin D analogs. More specifically, orlistat may impair absorption of Vitamin D analogs such as cholecalciferol. Monitor clinical response (plasma calcium concentrations) to orally administered vitamin D analogs closely if used with orlistat. When this combination must be used, consider administering the vitamin D analog at least 2 hours before or after the administration of orlistat.  [drugbank_resource:DB00169_DB01083]"@en .
}